Trial Outcomes & Findings for Vacuum vs Manual Drainage During Unilateral Thoracentesis (NCT NCT03496987)

NCT ID: NCT03496987

Last Updated: 2023-07-14

Results Overview

Difference in pain between pre-procedural pain and during drainage pain as measured as the difference between a pre-procedural NPSS pain score (range from 0 (no pain) to 10 (maximum pain)). This was asked again during drainage and the difference between the two was recorded. The values ranged from -10 to 10 (with a more negative number representing a decrease in pain and a more positive number representing an increase in pain) The scale used is called The Numeric Pain Rating Scale. With ratings from 0-10. Zero is the least amount of pain experienced while 10 is the worst pain possible.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

100 participants

Primary outcome timeframe

5-20 minutes

Results posted on

2023-07-14

Participant Flow

Inpatients, who were awake, consentable, and undergoing unilateral thoracentesis

Participant milestones

Participant milestones
Measure
Manual Drainage
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Overall Study
STARTED
49
51
Overall Study
COMPLETED
49
51
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=51 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Total
n=100 Participants
Total of all reporting groups
Age, Continuous
68.5 years
STANDARD_DEVIATION 16.2 • n=49 Participants
65.6 years
STANDARD_DEVIATION 15.5 • n=51 Participants
67 years
STANDARD_DEVIATION 15.8 • n=100 Participants
Sex: Female, Male
Female
26 Participants
n=49 Participants
22 Participants
n=51 Participants
48 Participants
n=100 Participants
Sex: Female, Male
Male
23 Participants
n=49 Participants
29 Participants
n=51 Participants
52 Participants
n=100 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
49 participants
n=49 Participants
51 participants
n=51 Participants
100 participants
n=100 Participants

PRIMARY outcome

Timeframe: 5-20 minutes

Population: 1 patient was excluded from analysis from the Vacuum Bottle Drainage arm from the original 51 enrolled because of a technical problem with the drainage system (not a complication).

Difference in pain between pre-procedural pain and during drainage pain as measured as the difference between a pre-procedural NPSS pain score (range from 0 (no pain) to 10 (maximum pain)). This was asked again during drainage and the difference between the two was recorded. The values ranged from -10 to 10 (with a more negative number representing a decrease in pain and a more positive number representing an increase in pain) The scale used is called The Numeric Pain Rating Scale. With ratings from 0-10. Zero is the least amount of pain experienced while 10 is the worst pain possible.

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=50 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Pain Change
0.53 Pre-post NPRS Pain Scale Score
Standard Deviation 1.7
1.43 Pre-post NPRS Pain Scale Score
Standard Deviation 2.7

SECONDARY outcome

Timeframe: 5-20 minutes

Population: 1 patient was excluded from analysis from the Vacuum Bottle Drainage arm from the original 51 enrolled because of a technical problem with the drainage system (not a complication).

Actual time of drainage in seconds for each patient.

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=50 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Time of Drainage
498.5 seconds
Standard Deviation 386.5
318.6 seconds
Standard Deviation 193

SECONDARY outcome

Timeframe: 5-20 minutes

Patients who had procedure termination prior to complete evacuation of the pleural contents (usually as a result of refractory pain or another symptom that the patient perceived).

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=51 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Number of Patients Who Had an Early Termination of Procedure
1 Participants
8 Participants

SECONDARY outcome

Timeframe: <7 days

Population: 1 patient was excluded from analysis from the Vacuum Bottle Drainage arm from the original 51 enrolled because of a technical problem with the drainage system (not a complication).

Any complications that occur as a direct result of the procedure. We tracked patients for 7 days after the procedure to capture any complications (which is typical clinical practice)

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=50 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Number of Patients Who Had a Complication as a Result of the Procedure
Pneumothorax
0 Participants
3 Participants
Number of Patients Who Had a Complication as a Result of the Procedure
Hemothorax
0 Participants
1 Participants
Number of Patients Who Had a Complication as a Result of the Procedure
Clinically Significant Pulmonary Edema
0 Participants
1 Participants

SECONDARY outcome

Timeframe: <7 days

Population: 1 patient was excluded from analysis from the Vacuum Bottle Drainage arm from the original 51 enrolled because of a technical problem with the drainage system (not a complication).

Clinical etiology of effusion

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=50 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Etiology of Effusion
Unknown
3 Participants
8 Participants
Etiology of Effusion
Malignant
13 Participants
8 Participants
Etiology of Effusion
Paramalignant
7 Participants
2 Participants
Etiology of Effusion
Heart Failure
7 Participants
8 Participants
Etiology of Effusion
Hepatic Hydrothorax
3 Participants
5 Participants
Etiology of Effusion
Post-Cardiothoracic Procedure
13 Participants
17 Participants
Etiology of Effusion
Parapneumonic
3 Participants
2 Participants

SECONDARY outcome

Timeframe: <20 minutes

Population: 1 patient was excluded from analysis from the Vacuum Bottle Drainage arm from the original 51 enrolled because of a technical problem with the drainage system (not a complication).

Volume of effusion drained (in mL)

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=50 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Volume of Effusion
1023 milliters
Standard Deviation 674
1143 milliters
Standard Deviation 775

SECONDARY outcome

Timeframe: <20 minutes

Laterality of effusion (left or right)

Outcome measures

Outcome measures
Measure
Manual Drainage
n=49 Participants
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=51 Participants
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Laterality of Effusion
Left
17 Participants
23 Participants
Laterality of Effusion
Right
32 Participants
28 Participants

Adverse Events

Manual Drainage

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Vacuum Bottle Drainage

Serious events: 5 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Manual Drainage
n=49 participants at risk
Patients undergo drainage of pleural fluid via manual (syringe) system
Vacuum Bottle Drainage
n=51 participants at risk
Patients undergo drainage of pleural fluid via a vacuum bottle system (evacuated cylinder) Vacuum Bottle Drainage: Patients undergo drainage via vacuum bottles
Respiratory, thoracic and mediastinal disorders
Pneumothorax
0.00%
0/49 • 1 month following procedure
5.9%
3/51 • Number of events 3 • 1 month following procedure
Respiratory, thoracic and mediastinal disorders
Clinically Significant Pulmonary Edema
0.00%
0/49 • 1 month following procedure
2.0%
1/51 • Number of events 1 • 1 month following procedure
Respiratory, thoracic and mediastinal disorders
Hemothorax
0.00%
0/49 • 1 month following procedure
2.0%
1/51 • Number of events 1 • 1 month following procedure

Other adverse events

Adverse event data not reported

Additional Information

Jonathan Puchalski, MD

Yale University School of Medicine

Phone: 2037375699

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place